|
1. Congressional Budget Office: Sources of Growth in Projected Federal Spending on Medicare &. Medicaid. (2007)
2. Centers for Disease Control & Prevention: Chronic Disease Overview Costs of Chronic Disease Cost Effectiveness Prevention (Nov 2008).
3. U.S. Healthcare: world Beaten; Bernard Wasow, The Century Foundation 5/3/06
4. World Health Organization, Assess the worlds health system, Press release WHO/44 June 21, 2000
5. Roehr B, Health care in U.S. ranks lowest among developed countries. BMJ 337 July 2008
6. CIA World Factbook 2008
7. Measuring the Health of Nations; Health Affairs Jan. 8, 2008 vol 98 Nolte E, Mckee M.
8.U.S. Diabetes rate nearly doubled in 10 years. Medical News Today, Oct. 31, 2008 Paddock, C
9. Beckett LA, Herbert LE, Scherr PA, Evans DA. Annual incidence of Alzheimers disease in the U.S. projected to the years 2000-2050. Alzheimers Disease Assoc. Disord. 2001 Oct-Dec; 15(4) 169-173
10. Ullman A, Pasteur-Koch; Distinctive ways of thinking about infectious diseases. 2007
11. Louis Pasteur; Catholic Encyclopedia, N.Y. Robert Appelton Co. 1913
12. Nair U, Bartsch H, Nair J. Prevention of Degenerative diseases; clues from studies investigating oxidative stress; Brussels Nov. 13, 2002, Mutagenesis vol 18 No. 5 pg. 477-483 Sept. 2003
13. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 11: 298-300 1956
14.Korman K, Interleukin-1 genetics, inflammatory mechanisms and nutrigenic opportunities to modulate diseases of aging. Amer. J of Clin. Nutr. Vol 83, No 2 pg. 4755-4835 Feb. 2006
15. Munch G, Thome J, Foley P, Schinzel R, Riederer P. Advanced Glycation endproducts in aging and alzheimers disease. Brain res. Rev. vol 23 issue 1-2 feb 1997 pg.134-143
16. Robertson KD, DNA Methylation and Human disease. Nat. Rev Genet. 2005 Aug; 6(8) 591-616
17. Marnett LJ, Oxyradicals and DNA damage. Carcinogenesis (2000) 21(3), 361-370
18. Halliwell B, Oxidative Stress and Cancer, have we moved forward? J Biochem. (2007) 401 (1-11)
19. Heistad DD, Oxidative Stress and Vascular disease. Ateriosclerosis, Thrombosis and Vascular Biology 2006; 26: 689
20.Kregel KC, Zhang HJ. An Integrated view of Oxidative Stress in Aging: basic mechanisms, functional effects and pathological considerations. Am J. Phsiol Regul Integr Comp Physiol. 292: R18-R36 (2007)
21. Opal SM, De Palo VA. Anti Inflammatory Cytokines. Chest 2000 Apr; 117(4): 1162-72
22. Samanta S, Perkinton MS, Morgan M, Williams R. Hydrogen Peroxide enhances signal-responsive arachodonic acid release from neurons. J. Neurochem. May 1998
23. Bailey AJ, Molecular mechanisms of aging in connective tissues. Mech Aeging Dev. (2001) vol 122, issue 7 pg. 735-755
24. Chappey O, Dosquet C, Wautier M, Wautier J. Advanced Glycation end products, oxidant stress and vascular lesions. Eur. J Clin Inv. Feb 1997 27:2
25. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B and Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Eng. J. Med. Vol 324: 1149-1155 Apr 25, 19991 No. 17
26. Available at; http://www.fda.gov/ohrms/dockets/AC/07/briefing/2007__02_01_FDA%20 Report%200n%20Science%20and%20Tecnology
27. Lee HC, Wei YH. Oxidative stress, mitochondrial DNA, Mutation and Apoptosis in Aging. Exp. Biol. Med. 232: 592-606 (2007)
28. Rajindar S, Weindruch R. Oxidative stress, Caloric restriction and Aging. Science July 5,1996
29. Sarkar D, Fisher P. Molecular mechanisms of aging associated inflammation. Cancer Letters, vol 236 Issue 1 pg 13-23
30. NIA workshop on Inflammation, inflammatory mediators and Aging. Bethesda MD. Sept 1-2 2004
31. Ulrich P, Cerami A, Protein glycation, diabetes and aging Recent Prog. Horm. Res 2001;56: 1-21
32. Oakes C, Smiraglia D, Plass C, Trasler Jm, Robaire B. Aging results in hypermethylation of ribosomal DNA in sperm and liver of male rats. PNAS Feb 18, 2003 vol 100 No. 4 1775-1780
33. Beal MF. Aging, energy, oxidative stress in neurodegenerative diseases. Annals of Neurology 1995
34. Ceriello A, Motz E. Is Oxidative stress the pathogenic mechanism underlying insulin resistence, diabetes and cardiovascular disease? The Common soil hypothesis revisited. Arteriosclerosis, Thrombosis and Vascular Biology 2004; 24:816
35. Duncan BB, Schmidt MI et al. Low grade systemic inflammation and the development of type 2 diabetes, The atherosclerosis risk in communities study Diabetes 52: 1799-1805 2003
36. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann. N.Y. Acad. Sci. 2004 Dec; 1035: 104-116
37. Komman KS. Interleukin-1 genetics, inflammatory mechanisms and nutrigenic opportunities to modulate diseases of aging. Amer. J. Clin. Nutr. Nov 2004
38. Minghetti L. Role of inflammation in neurodegenerative diseases, inflammatory diseases and infection. Current Opinion in Neurology June 2005 18(3): 315-321
39. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults. Annals of Int. Med. Sept 21 , 2004
40. Ladesma MD, Bonay P, Avila J. T Protein from Alzheimers disease patients is glycated at its tubulin-binding domain J. of Neurochem. 1995 vol 65 No. 4 pp 1658-1664
41. Costello JF, Plass C. Methylation Matters Med. Genet. May 2001 38:285-303
42. Robertson KD. DNA methylation and human disease. Nat. Rev Genet. Aug, 2005 6(8) 597-616
43. Preamble to the Constitution of the WHO as adapted by the International Health Conference 19-22 June 1946
44. Alpco Diagnostics www.alpco.com
45. Milne G, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2 Isoprostanes as a biomarker of oxidative stress. Nature Protocols 2007 2(1) 221-226
46. Handbook of Lipoprotein Testing by Nader Rifai and Russel Warnick 1997 pg465
47. Bolin C, Cardozo-Pelaez F. Assessing biomarkers of oxidative stress; analysis of guanosine and oxidized guanosine nucleotide triphosphates by high performance liquid chromatography with electrochemical detection. J. of Chromatography vol 856 Issues 1-2 Sept 1, 2007 pg 121-130
48. www.americanheart.org
49. http://www.prognostix.com
50. www.lef.org
51. www.endocrineweb.com/diabetes
52. http://www.freshpatents.com/Age-2-aptamer-dt20090122ptan20090023672.php?type=description
53. Fryer RH, Wilson BD, Gubber DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arteriosclerosis Thrombosis Sep 93 13(9): 1327-1333
54. Singh KK, Smiraglia DJ. Researchers link defects in mitochondria to abnormal nuclear genome packaging in cancer cells. J. Cancer Biology & Therapy Sept 12, 2008
55. Guttman J. The Ultimate Glutathione handbook Publ. Guttman & Schettini Montreal, Canada 1998
56. Corpas FJ et al; The expression of different superoxide dismutase forms is cell type dependent in olive leaves. Plant and cell Physiology 2006 47(7): 984-994
57. http://www.drmyhill.co.uk/test.cfm?id=87
58. http://www.callutheran.edu/Academic_Programs/Departments/BioDev/omn/catalase/cat1.htm
59. http://wwwclinchem.org/cgi/reprint/9/6/763.pdf
60. http://www.metametrix.com/content/DirectoryofServices/0040Fattyacids-plasma
61. Coding for Diseases of the nervous system and sense organs ICD-9-CM pg 315-320
62..http://www.neurorelief.com/index.php?option=com_content&task=category§ion=127id=40&itemid=46
63. http://www.downtoearth.org/articles/minerals.htm
64. Quantum Mechanics, The Uncertainty Principle. www.aip.org/history/heisenberg/po8.htm
65. Packer L, Colman C. The Antioxidant Miracle 1999 John Wiley & Sons Inc.
66. http://www.phyto.co.za
67. http://www.hbs.edu/centennial/conversation/managinghealthcare
68. Brownlee, S. Why does healthcare cost so much? AARP July 2008
69. Johnston CS, Meyer CG, Srilekshmi JC, Vitamin C elevates red blood cell glutathione in healthy adults. 70. Vouldoukis I, Conti M, Krauss P et al. Supplementation with Gliadin-combined plant superoxide dismutase extract provides antioxidant defense against oxidative stress. Phytother Res 2004 Dec; 18(12): 957-962
71. Li G, Yang J, Ren B, Wang Z. Effect of Lyceum Barbarum L on defending free radicals of mice caused by hypoxia. Wei Sheng Yan Jiu 2002 Feb; 31(1): 30-1
72. Bagis S, Tamer L, Sahin G et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005 Apr; 25(3): 188-190
73. Seher Akhtar Khan. Effects of DHEA on Ubiquinone and catalase in the livers of male F-344 rats. Biol & Pharm Bulletin vol 28 (2005) No 7 1301
74. Yasuhiro Yoshioka et al, Nitric oxide protects macrophages from hydrogen peroxide induced apoptosis by inducing the formation of catalase. J. of Immunol. 2006 176: 4675-4681
75. Barja G, Rate of generation of oxidative stress related damage and animal longevity. Free Radical Biology and Medicine vol 33, Issue 9 Nov 2002 pg 1167-1172
76. Wilkinson IB, Megson IL, MacCallum H et al, Oral Vitamin C reduces arterial stiffness and platelet aggregation in humans.. J. CardioVasc. Pharmacol. 1999 Nov; 34(5): 690-693
77. Fogarty A, Lewis Sa, Scrivener SL et al, Corticosteroid sparing effects of vitamin C and magnesium in asthma: a randomized trial. Respir Med. 2006 Jan; 100(1): 174-179
78. Meydani M, Vitamin E and Atherosclerosis: Beyond prevention of LDL oxidation. J. Nutr 2001 Feb; 131(2): 361s-368s
79. Kline K et al. Vitamin E, Mechanisms of action as tumor cell growth inhibitor. J Nutr 2001 Jan; 131(1): 161s-163s
80. Crane FL. Biochemical functions of CoEnzyme Q10. J of the Amer. Coll. Of Nutr. Vol 20 No 6 591-598 (2001)
81. Hargreaves IP. Ubiquinone: Cholesterols reclusive cousin. Annal. Clin. Biochem. 2003; 40: 207-218
82. Thomas SR, et al. Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for CoQ10 in atherogenesis.
83. Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha lipoic acid. Free Radical Biology and Medicine vol22 Issues 1-2 1997 pg 359-378
84. Micozzi MS, Beecher GR, Taylor PR, Khachik F. Carotenoid analysis of selected raw and cooked foods, Associated with a lower risk for cancer. J. of the NCI vol 82, No 4 pg 282-285 Feb 21, 1990
85. Chew BP, Park JS. Carotenoid action on the immune response. J. of Nutr. 134: 2578-2618 Jan, 2004
86. Giovannucci E. A review of epidemiological studies of tomatoes, lycipene and prostate cancer. Exp. Biol. Med 2002 Nov; 227(10): 852-859
87. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. Effects of Lycopene on spontaneous mammary tumor development in SHN virgin mice. Anti Cancer Res. 1995, July-Aug. 15(4) 1173-80
88. Kohlmeier L, Kark JD, Gomez-Garcia E. et al. Lycopene and myocardial infarction risk in the EURAMC study. Am. J. Epidemiol. 1997 Oct 15; 146(8): 618-626
89. Mitchell P, Smith W, Cumming RG, Flood V, Rotchina E, Wang JJ Nutritional factors in the development of age related eye disease. Asia Pac. J. Clin Nutr. 2003; 12 Suppl;55
90. Alves-Rodriguez A, Shao A. The science behind Lutein. Toxicol Lett. 2004 Apr 15, 150(1): 57-83
91. Nishino H, Murakosh M et al Carotenoids in cancer chemoprevention Cancer Metasteses Rev. 2002; 21(3-4): 257-264
92. Mozaffarieh M, Saeu S, Wedrich A. The role of the carotenoids, lutein and zeaxanthin in protecting against age related macular degeneration. A review based on controversial evidence. Nutr. J 2003 Dec 11; 2(1): 20
93. Gale CR, Hall NF, Phillips DI< Martyn CN. Lutein and Zeaxanthin status and risk of age related macular degeneration. Invest. Opthalmol vis sci 2003 Jun; 44(6): 2461-2465
94. Knekt P, Kumpulainen J, Jarvinen R Rissanen H, Heliovaara M, Reunannen A Hakulinen T& Aromaa A. Flavinoid intake and the risk of chronic diseases. Amer. J Clin Nutr. Vol 76 no 3 560-68 Sept. 2002
95. Peluse MR, Flavinoids attenuate cardiovascular disease,, inhibit phosphodiesterase and modulate lipid homeostasis in adipose tissue and liver. Exp. Biol & Med. 231: 1287-1298 (2006)
96. Chen D, Daniel KG, Kuhn et al. Green tea and polyphenols in cancer prevention. Front. Biosci. 2004 Sept; 9:2618-2631
97. Sano J, Inami S, Seimiye K et al. Effects of Green Tea intake on the development of coronary disease. Circ. J. 2004 july; 68(7): 665-670
98. Weinrib O, Mandel S, Amit T, Youdim MB; Neurological mechanisms of green tea polyphenols in Alzheimers and Parkinsons Diseases. J.Nutr. Biochem 2004 Sep; 15(9): 506-516
99. Hertog MG et al; Dietary antioxidant flavinoids and risk of coronary artery disease: The Zutphen study. Lancet 1993: 342: 1007-1011
100. Keli SO et al. Dietary flavinoids, antioxidant vitamins and incidence of stroke: The Zutphin study. Arch. Int. Med. 1996 Mar 5; 156(6): 637-642
101. Wang H, et al; Structure-activity relationships of quercetin in antagonizing hydrogen peroxide induced calcium dysregulation in cells. Free. Rad. Biol. Med. 1999, 27(5/6): 683-694
102. Sharma DP; Antioxidant activity of Curcumin related compounds. Biochem. Pharmacol. 1976 Aug 1; 25(15): 1811-1820
103. Nirmala C, PuvanaKrishnan R, Protective role of curcumin against isoproterenol induced myocardial infarction in rats. Molecular & Cellular Biochem. Vol 159, no 2 Sept 1996 pg 85-93
104. Huang MT, Newmark HL, Frankel K. Inhibiting effects of curcumin on tumorogenesis in mice. J. Cell. Biochem. Vol 67 Issue S27 7, Dec 1998 pg 26-34
105. Elstner EF, Kleber E; Radical scavenger properties of leucocyanidine. In: Das NP, ed. Flavinoids in Biology & Medicine 111. Current Issues in Flavinoid Research: Natnl. Univ. Singapore Press (1990) 227-235
106. Maritm A, Dene BA, Sanders RA, Watkins JB. Effects of Pycnogenol treatment in oxidative stress in streptozotocin induced diabetic rats. J. Biochm. Mol. Toxicol. (2003) 17(3): 193-199
107. Knekt P, Jarvinen R, Reunanen A, Maatala J. Flavinoid intake and coronary mortality inFinland: a cohort study. BMJ 1996, 312: 47481 24 Feb.
108. Youdim KA et al, Incorporation of the elderberry anthocyanins by endothelial cells increases protection against oxidative stress. Free Rad. Biol. Med 2000 29: 51-60
109. Ingram DK, Anson RM, Decabo R, et al; Development of calorie restriction mimetics as a pro longevity strategy. Ann. N.Y. Acad. Sci. 2004 jun: 1019: 412-423
110. LaGauge M, Argmann C, Gerhart-Hines Z et al; Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell. 2006 Dec 15; 127(6): 1109-1122
111. Ignatowicz E, Baer-Dubowska W; Resveratrol, a natural chemopreventive against degenerative disease. PO1 J. Pharmacol. 2001 Nov; 53(6): 557-569
112. Aviram M, Dornfeld L, Rosenblat M et al; Pomegranite juice consumption reduced oxidative stress, atherogenic modifications to LDL and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E deficient mice. Am. J. Clin. Nutr. 2000 May; 71(5): 1062-1076
113. Kim ND, Mehta R, Yu W, et al; Chemopreventive and adjuvant therapeutic potential of pomegranate for human breast cancer. Breast cancer Res. Treat. 2002 feb; 71(3); 203-217
114. Pablos MI, Reiter RJ, Chuang JI, Ortiz GG, Guerrero JM, Sewerynek E, Agapito MT, Melchiorri D Deneke LR; Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen. J. Appl. Physiol. 83(2): 354-358 Aug.
115. Blask DE, Hill SM. Effects of melatonin on cancer: studies on the MCF-7 human breast cancer cells in culture. J. Neural. Transm. Suppl. 1986; 21: 433-449
116. Kelley VE, Ferretti A. Izui S, et al; A fish oil diet rich in eicosopentanoic acid reduces cyclooxygenase metabolites and suppresses lupus in MRL-1pr mice. J. Immunol. 1985 Mar; 134(3) 1914-1919
117. hu FB, Willett W; Optimal diets for prevention of coronary heart disease. JAMA vol 288, No .20 Nov 27, 2002 pg. 2569-2578
118. Horrocks LA, Yeo YK; health benefits of Docosahexanoic acid (DHA) Pharmacol. Res. Vol 40, Issue 3 Sept. 1999 pg 211-225
|